Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.
Before a recommendation for antimalarial drug use in pregnancy is made, it is essential that we understand the potential risks involved and have mechanisms in place to monitor risk during treatment. This requires data on drug disposition during pregnancy and potential toxicological liabilities to th...
Principais autores: | Ward, SA, Sevene, E, Hastings, I, Nosten, F, Mcgready, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2007
|
Registros relacionados
-
Antimalarial drugs in pregnancy: a review.
por: Nosten, F, et al.
Publicado em: (2006) -
Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.
por: Nosten, F, et al.
Publicado em: (1990) -
The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy.
por: Mcgready, R, et al.
Publicado em: (2002) -
Clinical pharmacokinetics of antimalarial drugs.
por: White, N
Publicado em: (1985) -
Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: a systematic review.
por: Mcgready, R, et al.
Publicado em: (2011)